Livia Veress, MD
Professor, Pediatrics-Pulmonary Medicine

Director, Center of Advanced Drug Development
Clinic (720) 777-6181
Print Profile
Email Profile
Featured Provider Photo

Gender: Female
Languages: English, Hungarian
Department, Section/Division: Pediatrics-Pulmonary Medicine

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
More providers at this location

Hospital Affiliation
  • Children's Hospital Colorado
Center Affiliations

Specialty Information

Specialties
  • Pediatrics - Pediatric Critical Care Medicine
  • Pediatrics - Pediatric Pulmonology, Board Certification (2010)
  • Pediatrics, Board Certification (2005)
Conditions & Treatments
  • Critical Care
  • Long COVID
  • Lungs and Breathing
  • Chronic Mechanical Ventilation
  • Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
  • Interstitial Lung Disease
  • Interventional Pulmonology
  • Lung Development
  • Lung Disease
  • Neonatal Lung Diseases
  • Pulmonary Hypertension
  • Tracheostomy Dependence
  • Poisoning, Toxicology, Environmental Health
Clinical Interest for Patients
My many clinical interests include Bronchopulmonary Dysplasia, Airway Anatomical DIsorders, Congenital Lung Disorders, Plastic Bronchitis, Bronchiolitis Obliterans, Pulmonary Fibrosis, Congenital Heart Disease-Associated Lung Abnormalities, ARDS

Care Philosophy
I strive to provide an extremely thorough care for all my patients. I believe in treating the person as a whole, taking every aspect of a patient’s body and health into consideration during diagnosis and treatment.

Education & Training

Medical Schools:
  • MD, Louisiana State University School of Medicine in New Orleans (2002)

Undergraduate Schools:
  • BS, Tulane University (LA) (1996)

Residency Program:
  • Louisiana State University Program, Pediatrics (2005)

Fellowships:
  • University of Colorado, Pediatric Pulmonology (2010)
  • University of Colorado, Pediatric Critical Care Medicine (2006)

Recognition & Awards

  • Poster Competition, Countermeasures Against Chemical Threats (2011)
  • Travel Award, Countermeasures Against Chemical Threats (2011)
  • Travel Award, Countermeasures Against Chemical Threats (2010)
  • Young Faculty Awards, Children's Environmental Health Center (2010)
  • Travel Award, American Thoracic Society (2009)
  • Travel Award, Countermeasures Against Chemical Threats (2009)

Professional Memberships

  • American Academy of Pediatrics (AAP), Resident Fellow
  • American Medical Association, Member
  • American Thoracic Society (ATS), Member
  • EAPCCT, Member
  • SOT, Full Member

Research & Grants

Grants
  • R01: Vascular Injury and Repair Predict Divergent Late Onset Cardiovascular Morbidities After Chlorine and Sulfur Mustard Exposure (2023)
    NIH/NIEHS, $1386277
  • Alteplase for Sulfur Mustard Gas (SMG) Inhalation (2019)
    Genentech/BARDA/HHS, $12300000
  • U01: Anticholinergic and Antiepileptic Therapies for Chlorine Toxicity (2018)
    NIH/NINDS, $1300000
  • U54: Project 2. Development of antidotes for toxic gases (2016)
    NIH/NIEHS, $2400000
  • Advanced Development of Alteplase as a Medical Countermeasure for Pulmonary Injury Associated with Sulfur Mustard Inhalation - Proof of Concept in a Swine Model (2015)
    BARDA/HHS, $12900000
Research interests for Patients:
Translational research, acute lung injury/acute respiratory distress syndrome, bronchiolitis obliterans, interstitial lung fibrosis, pulmonary wound repair and tissue regeneration, chemical inhalation injury, airway coagulation, fibrinolytic and antifibrotic drug therapies, drug development, plastic bronchitis, pulmonary hypertension, pulmonary vascular thrombosis, endothelialitis, microvascular thrombosis, immunothrombosis, severe COVID-19 illness, lung growth abnormalities after in utero environmental exposures, cardiac dysfunction, septic shock, aspiration-induced injury and other pulmonary toxicology.

Information for Referring Providers

Clinical Interests for Referring Providers
My many clinical interests include Bronchopulmonary Dysplasia, Airway Anatomical DIsorders, Congenital Lung Disorders, Plastic Bronchitis, Bronchiolitis Obliterans, Pulmonary Fibrosis, Congenital Heart Disease-Associated Lung Abnormalities, ARDS

Research Interest for Referring Providers
Translational research, acute lung injury/acute respiratory distress syndrome, bronchiolitis obliterans, interstitial lung fibrosis, pulmonary wound repair and tissue regeneration, chemical inhalation injury, airway coagulation, fibrinolytic and antifibrotic drug therapies, drug development, plastic bronchitis, pulmonary hypertension, pulmonary vascular thrombosis, endothelialitis, microvascular thrombosis, immunothrombosis, severe COVID-19 illness, lung growth abnormalities after in utero environmental exposures, cardiac dysfunction, septic shock, aspiration-induced injury and other pulmonary toxicology.
Clinic Phone: (720) 777-6181
Fax Phone: (720) 777-7283
Lab Phone: (303) 724-7337